Comments on: Amalaki: Why Indian Gooseberry Deserves More Attention Than Vitamin C

By: Tom Wilson

Tom Wilson — Wed, 10 Jun 2026 06:37:36 +0000

The final takeaway feels balanced: amalaki offers a credible signal for certain markers but isn’t a proven replacement for standard cardiovascular or diabetes care.

By: Brian Cooper

Brian Cooper — Sun, 31 May 2026 11:05:37 +0000

It’s noteworthy that the article separates classical doses like 3, 6 g dried powder from concentrated extracts, stressing they aren’t interchangeable.

By: Kevin Martin

Kevin Martin — Thu, 21 May 2026 17:24:16 +0000

I appreciate the reminder to check product labels for botanical identity, plant part, dose, and contaminant testing before using amalaki therapeutically.

By: Nicole Hayes

Nicole Hayes — Mon, 11 May 2026 19:46:09 +0000

The piece cautions that claims about hepatoprotection or neuroprotection remain mostly preclinical, so human conclusions should stay limited to tested preparations.

By: Rachel Adams

Rachel Adams — Fri, 01 May 2026 21:06:01 +0000

Reading about the classical Ayurvedic profile (sweet, sour, pungent, bitter, astringent) makes clear why amalaki is considered tridoshajit.

By: Mark Bennett

Mark Bennett — Tue, 21 Apr 2026 21:04:42 +0000

The 2019 trial’s proprietary extract, standardized to 35% polyphenols, showed lipid improvements, yet the article reminds us not to swap it for statins.

By: Megan Parker

Megan Parker — Sat, 11 Apr 2026 23:51:53 +0000

I wonder how the variability in polyphenol content across extracts might affect real-world results when people pick a random amla powder.

By: Chris Morgan

Chris Morgan — Thu, 02 Apr 2026 04:45:35 +0000

The discussion on preparation standards stood out, especially how drying changes the material tested and why a universal vitamin C number doesn’t apply.

By: Laura Mitchell

Laura Mitchell — Mon, 23 Mar 2026 11:18:05 +0000

It’s helpful that the Ayurvedic Pharmacopoeia lists both ascorbic acid and tannins together, showing why reducing amalaki to a single nutrient misses the point.

By: Greg Taylor

Greg Taylor — Sun, 22 Mar 2026 16:30:00 +0000

The data on Amalaki for Pitta skin conditions is interesting. I have rosacea and have been looking for systemic interventions beyond topical approaches. If the cooling anti-inflammatory effect on Rakta dhatu is real, this could be relevant. Has anyone used Amalaki specifically for rosacea?